<DOC>
	<DOCNO>NCT02912585</DOCNO>
	<brief_summary>Infections main cause morbidity mortality low birth weight infant . Use mother 's breast milk feed baby associate decreased risk acquire nosocomial infection . This protective effect assign plurality immune component human milk . However , clinical instability preterm newborn first day life result delay initiation enteral nutrition . Thus , alternative method colostrum administration investigate , oropharyngeal administration evidence would safe feasible perform child admit NICU first hour life . Objective : To evaluate immune stimulatory effect oropharyngeal administration colostrum incidence sepsis low birth weight preterm infant .</brief_summary>
	<brief_title>Oropharyngeal Administration Colostrum</brief_title>
	<detailed_description>Background : Infections main cause morbidity mortality low birth weight infant . Use mother 's breast milk feed baby associate decreased risk acquire nosocomial infection . This protective effect assign plurality immune component human milk . However , clinical instability preterm newborn first day life result delay initiation enteral nutrition . Thus , alternative method colostrum administration investigate , oropharyngeal administration evidence would safe feasible perform child admit NICU first hour life . Objective : To evaluate immune stimulatory effect oropharyngeal administration colostrum incidence sepsis low birth weight preterm infant . Methods : This prospective , randomize blind study include infant less 34 week gestational age birth weight less 1,500 g , 15 July 2013 15 July 2015 . The baby divide initially two group oropharyngeal administration mother 's milk : Group 1 - underwent oropharyngeal administration mother 's milk Group 2 - underwent oropharyngeal administration sterile water , consider inert substance . Newborns drawn Group 1 possible obtain sufficient mother 's milk volume constitute third group call Group 3 receive oropharyngeal administration donor breast milk . Oropharyngeal administration initiate within first 48-72 hour life maintain 48 hour . Before oropharyngeal administration , 24 hour 14 day , sample blood urine collect newborn IgA lactoferrin dosage .</detailed_description>
	<criteria>Birth weight &lt; 1500 g gestational age &lt; 34 week congenital anomaly gastrointestinal disorder maternal history substance abuse positive maternal HIV status .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Days</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>colostrum</keyword>
</DOC>